Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.09 - Mesothelioma
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Mesothelioma
-
+
P1.09-008 - A 4-microRNA Signature in Serum Can Discriminate Between Non-Small-Cell Lung Cancer and Malignant Pleural Mesothelioma
09:30 - 09:30 | Presenter: Michaela B Kirschner | Author(s): C. Leygo, S. Burgers, T. Korse, D. Van Den Broek, Nico Van Zandwijk, Glen Reid
- Abstract
Loading...
-
+
OA 02 - Mesothelioma: Challenges For New Treatment
- 11:00 - 12:30
- 10/16/2017
- Location: F205 + F206 (Annex Hall)
- Type: Oral
- Track: Mesothelioma
- Moderators:S. Hasegawa, Anna Nowak
-
+
OA 02.01 - Randomized Phase II Study of Anetumab Ravtansine or Vinorelbine in Patients with Malignant Pleural Mesothelioma
11:00 - 11:10 | Presenter: Hedy Lee Kindler | Author(s): Silvia Novello, Dean A Fennell, G. Blumenschein, A. Bearz, G.L. Ceresoli, J.G. Aerts, J. Spicer, P. Taylor, A. Greystoke, K. Nackaerts, Luana Calabro, S. Burgers, R. Jennens, A.F. Sporchia, A. Walter, J. Siegel, B.H. Childs, C. Elbi, R. Hassan
- Abstract
Loading... -
+
OA 02.02 - Ipilimumab and Nivolumab in the Treatment of Recurrent Malignant Pleural Mesothelioma: A Phase II Study
11:10 - 11:20 | Presenter: Paul Baas | Author(s): M. Disselhorst, E. Harms, H. Van Tinteren, J. Quispel-Janssen, K. Monkhorst, S. Burgers
- Abstract
Loading...
-
+
P2.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P2.04-013 - ElevatION:NSCLC-101 – A Phase 1b Study of PDR001 Combined with Chemotherapy in PD-L1 Unselected, Metastatic NSCLC Patients
09:30 - 09:30 | Presenter: Enriqueta Felip | Author(s): Johan F. Vansteenkiste, Frances A Shepherd, Luis Paz-Ares, Fabrice Barlesi, S. Burgers, C. Cai, F. Kiertsman, J. Scott, T. McCulloch, Y.Y. Lau, D. Morgensztern
- Abstract
Loading...
-
+
P3.14 - Radiotherapy
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
-
+
P3.14-005 - Treatment Response Measured on Conebeam-CT During Concurrent Chemoradiation for NSCLC Patients
09:30 - 09:30 | Presenter: Margriet Kwint | Author(s): B. Stam, M.M.G. Rossi, S. Burgers, E. Aalbersberg, J. Sonke, J. Belderbos, Iris Walraven
- Abstract
Loading...